NCT05992103View on ClinicalTrials.gov

ABLATE WEIGHT 2 (Single-Stage Fundic Ablation Plus ESG for Weight Loss)

NAActive, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 14, 2023

Primary Completion Date

April 14, 2025

Study Completion Date

May 15, 2025

Conditions
Obesity
Interventions
PROCEDURE

Fundic Ablation in Combination with Endoscopic Sleeve Gastroplasty

Fundic mucosal ablation followed by endoscopic sleeve gastroplasty in the treatment of adults with obesity

DEVICE

Fundic Mucosal Ablation with ERBE HybridAPC

Fundic mucosal ablation utilizing approved ERBE HybridAPC

DEVICE

Apollo ESG

Using only Apollo ESG as approved per label

Trial Locations (1)

27513

True You Weight Loss, Cary

All Listed Sponsors
lead

True You Weight Loss

OTHER

NCT05992103 - ABLATE WEIGHT 2 (Single-Stage Fundic Ablation Plus ESG for Weight Loss) | Biotech Hunter | Biotech Hunter